Dana Investment Advisors »

Halozyme Therapeutics shares owned by Dana Investment Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Dana Investment Advisors from 13F filings

Historical chart of Dana Investment Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Dana Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Dana Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $249k 6.5k 38.20
2023-06-30 $583k 16k 36.07
2023-03-31 $5.5M 145k 38.19
2022-12-31 $5.1M 90k 56.90